Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy

S Trino, D Lamorte, A Caivano, L De Luca, A Sgambato… - Leukemia, 2021 - nature.com
In the era of precision medicine, liquid biopsy is becoming increasingly important in
oncology. It consists in the isolation and analysis of tumor-derived biomarkers, including …

Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid

M Karami Fath, J Azami, N Jaafari… - Cellular & Molecular …, 2022 - Springer
Exosomes, known as a type of extracellular vesicles (EVs), are lipid particles comprising
heterogeneous contents such as nucleic acids, proteins, and DNA. These bi-layered …

The role of bone marrow mesenchymal stem cell derived extracellular vesicles (MSC-EVs) in normal and abnormal hematopoiesis and their therapeutic potential

AK Batsali, A Georgopoulou, I Mavroudi… - Journal of clinical …, 2020 - mdpi.com
Mesenchymal stem cells (MSCs) represent a heterogeneous cellular population responsible
for the support, maintenance, and regulation of normal hematopoietic stem cells (HSCs). In …

[HTML][HTML] Extracellular vesicles in the hematopoietic microenvironment

JT Butler, S Abdelhamed, P Kurre - Haematologica, 2018 - ncbi.nlm.nih.gov
Self-renewal and differentiation are defining characteristics of hematopoietic stem and
progenitor cells, and their balanced regulation is central to lifelong function of both blood …

MicroRNAs as new biomarkers for diagnosis and prognosis, and as potential therapeutic targets in acute myeloid leukemia

S Trino, D Lamorte, A Caivano, I Laurenzana… - International journal of …, 2018 - mdpi.com
Acute myeloid leukemias (AML) are clonal disorders of hematopoietic progenitor cells which
are characterized by relevant heterogeneity in terms of phenotypic, genotypic, and clinical …

Emerging bone marrow microenvironment-driven mechanisms of drug resistance in acute myeloid leukemia: tangle or chance?

M Ciciarello, G Corradi, D Forte, M Cavo, A Curti - Cancers, 2021 - mdpi.com
Simple Summary Despite high rates of remission obtained with conventional chemotherapy,
the persistence of leukemic cells after treatments, eventually exiting in disease relapse …

Serum exosomal miR‐1269a serves as a diagnostic marker and plays an oncogenic role in non‐small cell lung cancer

X Wang, X Jiang, J Li, J Wang, H Binang, S Shi… - Thoracic …, 2020 - Wiley Online Library
Background Early diagnosis improves the prognosis for non‐small cell lung cancer
(NSCLC); therefore, there is a pressing need for effective diagnostic methods for NSCLC …

Circulating biosignatures in multiple myeloma and their role in multidrug resistance

SR Krishnan, M Bebawy - Molecular Cancer, 2023 - Springer
A major obstacle to chemotherapeutic success in cancer treatment is the development of
drug resistance. This occurs when a tumour fails to reduce in size after treatment or when …

Proteomics study of human cord blood reticulocyte-derived exosomes

M Díaz-Varela, A de Menezes-Neto, D Perez-Zsolt… - Scientific reports, 2018 - nature.com
Abstract Reticulocyte-derived exosomes (Rex), extracellular vesicles of endocytic origin,
were initially discovered as a cargo-disposal mechanism of obsolete proteins in the …

Combinatorial nanocarriers against drug resistance in hematological cancers: opportunities and emerging strategies

S Ghosh, R Lalani, V Patel, D Bardoliwala… - Journal of Controlled …, 2019 - Elsevier
Hematological cancers are a group of malignancies affecting human hematopoietic and
lymphoid tissues. Although the patients respond to treatment regimen during initial phases …